ROVIDA, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.367
EU - Europa 5.744
AS - Asia 1.729
SA - Sud America 62
OC - Oceania 56
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.999
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.326
PL - Polonia 2.127
RU - Federazione Russa 1.510
IT - Italia 604
HK - Hong Kong 540
IE - Irlanda 475
SE - Svezia 471
SG - Singapore 426
CN - Cina 313
JO - Giordania 132
DE - Germania 123
IN - India 117
GB - Regno Unito 114
FI - Finlandia 97
VN - Vietnam 81
UA - Ucraina 72
AU - Australia 55
BR - Brasile 50
ID - Indonesia 45
CA - Canada 38
CH - Svizzera 33
CI - Costa d'Avorio 29
FR - Francia 25
NL - Olanda 25
BE - Belgio 22
TW - Taiwan 17
TR - Turchia 14
AT - Austria 11
JP - Giappone 11
ES - Italia 8
MK - Macedonia 8
KR - Corea 7
EC - Ecuador 5
IL - Israele 5
PH - Filippine 5
RO - Romania 4
AE - Emirati Arabi Uniti 3
LK - Sri Lanka 3
MA - Marocco 3
AL - Albania 2
CL - Cile 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LT - Lituania 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
IM - Isola di Man 1
JM - Giamaica 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 14.999
Salva come PNG Salva come JPEG
Città #
Warsaw 2.127
Santa Clara 2.061
Fairfield 754
Chandler 538
Dublin 470
Hong Kong 444
Ashburn 394
Woodbridge 370
Seattle 330
Cambridge 290
Houston 265
Singapore 260
Wilmington 243
Florence 231
Ann Arbor 205
Jacksonville 149
Princeton 119
Lawrence 110
Beijing 108
Altamura 104
Boston 84
Dong Ket 72
Boardman 65
Mumbai 63
Buffalo 59
San Diego 58
Shanghai 58
Melbourne 54
Moscow 46
Kent 44
Jakarta 41
Falls Church 39
Medford 39
Pune 33
Munich 31
Abidjan 29
Bern 28
Los Angeles 26
Brussels 22
Milan 22
Norwalk 21
Portsmouth 21
Ottawa 19
Rome 19
Phoenix 18
London 17
Toronto 17
Council Bluffs 16
Yubileyny 15
Redwood City 14
Siena 13
Daan 12
Dearborn 12
Lauterbourg 12
Andover 11
Helsinki 11
Vienna 9
Guangzhou 8
Prato 8
Hillsboro 7
Redmond 7
Barcelona 6
Hyderabad 6
Izmir 6
Lappeenranta 6
Turin 6
West Jordan 6
Dallas 5
Frankfurt am Main 5
Fuzhou 5
Laurel 5
Nuremberg 5
Renton 5
Tappahannock 5
Ahmedabad 4
Cagliari 4
Cisano Bergamasco 4
Costa Mesa 4
Düsseldorf 4
Hangzhou 4
Istanbul 4
New York 4
Notre Dame 4
São Paulo 4
The Dalles 4
Zhengzhou 4
Castelliri 3
Chicago 3
Colombo 3
Detroit 3
Foggia 3
Islington 3
Kilburn 3
Kyoto 3
Lausanne 3
Lynchburg 3
Malang 3
Menlo Park 3
New Taipei City 3
Ohrid 3
Totale 10.933
Salva come PNG Salva come JPEG
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 324
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 303
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 295
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 291
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 290
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 282
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 277
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 277
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 273
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 269
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 267
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 267
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 254
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 240
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 237
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 222
Impact of ERK5 on the Hallmarks of Cancer 192
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 191
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 185
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 175
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 174
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 173
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 163
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 163
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 160
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 156
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 152
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 152
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 152
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 143
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 142
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 140
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 139
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 139
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 137
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 137
Fatty acids regulate the biology of cholangiocarcinoma cells 136
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 134
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 131
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 130
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 128
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 128
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 127
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 124
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 123
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 123
Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? 122
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 122
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 122
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 121
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 120
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 119
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 119
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 119
Tryptophan availability selectively limits NO-synthase induction in macrophages. 116
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 116
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 114
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 114
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 113
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 113
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 112
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 111
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 110
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 110
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 109
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 109
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 109
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 109
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 108
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 107
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 103
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 102
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 102
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 101
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 100
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 99
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 98
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 97
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 96
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 96
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 95
The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells 94
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 93
ERK5 inhibition elicits cellular senescence in human melanoma cells 92
L’oncogene fes e la fosfotirosino-fosfatasi citosolica a basso peso molecolare interferiscono con la proliferazione e l’adesione cellulare 91
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 91
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 91
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 91
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 89
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 88
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 87
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 87
Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation 85
Glucose Availability in Hypoxia Regulates the Selection of CML Progenitor Subsets with Different Resistance to Imatinib-Mesylate 85
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 83
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 83
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 82
Effects of a human myeloid chronic leukemia cell line (K562) on in vivo angiogenesis 80
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 78
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 76
Totale 14.296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020618 0 0 0 0 0 0 0 0 205 155 210 48
2020/20211.475 133 155 50 157 69 164 77 109 143 205 83 130
2021/2022940 59 66 44 56 50 54 49 54 68 59 140 241
2022/20232.234 189 366 125 159 155 382 299 142 284 16 67 50
2023/2024886 30 84 122 35 58 114 54 200 25 39 86 39
2024/20255.388 218 581 355 897 1.800 826 94 344 273 0 0 0
Totale 15.226